83_FR_31286 83 FR 31158 - Center for Scientific Review; Notice of Closed Meetings

83 FR 31158 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 128 (July 3, 2018)

Page Range31158-31159
FR Document2018-14310

Federal Register, Volume 83 Issue 128 (Tuesday, July 3, 2018) 
[Federal Register Volume 83, Number 128 (Tuesday, July 3, 2018)]
[Notices]
[Pages 31158-31159]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-14310]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Risk, Prevention, and Health Behavior Overflow.
    Date: July 17, 2018.
    Time: 11:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: John H. Newman, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3222, MSC 7808, Bethesda, MD 
20892, (301) 435-0628, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Vascular and Hematology AREA Application Review.
    Date: July 31, 2018.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Katherine M. Malinda, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4140, MSC 7814, Bethesda, MD 
20892, 301-435-0912, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; AREA: Immunology.
    Date: August 2, 2018.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Liying Guo, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4016F, Bethesda, MD 20892, 301-435-0908, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)


[[Page 31159]]


    Dated: June 28, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-14310 Filed 7-2-18; 8:45 am]
BILLING CODE 4140-01-P

31158 Federal Register / Vol. 83, No. 128 / Tuesday, July 3, 2018 / Notices DEPARTMENT OF HEALTH AND Contact Person: Ranga Srinivas, Ph.D., amended, notice is hereby given of the HUMAN SERVICES Chief, Extramural Project Review Branch, following meetings. National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, The meetings will be closed to the National Institutes of Health public in accordance with the 5365 Fishers Lane, Room 2085, Rockville, Center for Scientific Review; Amended MD 20852, (301) 451–2067, srinivar@ provisions set forth in sections mail.nih.gov. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Notice of Meeting Name of Committee: National Institute on as amended. The grant applications and Notice is hereby given of a change in Alcohol Abuse and Alcoholism Special the discussions could disclose the meeting of the Center for Scientific Emphasis Panel; SEP Review Member confidential trade secrets or commercial Review Special Emphasis Panel, July 19, Conflict Applications. property such as patentable material, Date: July 10, 2018. 2018, 08:00 a.m. to July 20, 2018, 06:00 and personal information concerning Time: 2:30 p.m. to 5:00 pm. p.m., National Institutes of Health, 6701 Agenda: To review and evaluate grant individuals associated with the grant Rockledge Drive, Bethesda, MD, 20892 applications. applications, the disclosure of which which was published in the Federal Place: National Institutes of Health, would constitute a clearly unwarranted Register on June 26, 2018, 83 FR Pg National Institute on Alcohol Abuse and invasion of personal privacy. 29803. Alcoholism, 6700 B Rockledge Drive, Name of Committee: Center for Scientific This meeting was changed from a 2- Bethesda, MD 20892 (Telephone Conference Call). Review Special Emphasis Panel; day meeting to a 1-day meeting. The Fellowships: Risk, Prevention, and Health Contact Person: Anna Ghambaryan, M.D., meeting is now July 19, 2018 from 8:00 Ph.D., Scientific Review Officer, Office of Behavior Overflow. a.m. to 6:00 p.m. The meeting is closed Extramural Activities, National Institute on Date: July 17, 2018. to the public. Alcohol Abuse and Alcoholism, National Time: 11:00 a.m. to 6:00 p.m. Dated: June 27, 2018. Institutes of Health, 5635 Fishers Lane, Agenda: To review and evaluate grant Rockville, MD 20852, anna.ghambaryan@ applications. Natasha M. Copeland, nih.gov. Place: National Institutes of Health, 6701 Program Analyst, Office of Federal Advisory Name of Committee: National Institute on Rockledge Drive, Bethesda, MD 20892 Committee Policy. Alcohol Abuse and Alcoholism Special (Virtual Meeting). [FR Doc. 2018–14215 Filed 7–2–18; 8:45 am] Emphasis Panel; SEP Review Member Contact Person: John H. Newman, Ph.D., BILLING CODE 4140–01–P Conflict Applications. Scientific Review Officer, Center for Date: July 13, 2018. Scientific Review, National Institutes of Time: 2:00 p.m. to 4:00 p.m. Health, 6701 Rockledge Drive, Room 3222, DEPARTMENT OF HEALTH AND Agenda: To review and evaluate grant MSC 7808, Bethesda, MD 20892, (301) 435– HUMAN SERVICES applications. 0628, newmanjh@csr.nih.gov. Place: National Institutes of Health, National Institute on Alcohol Abuse and Name of Committee: Center for Scientific National Institutes of Health Review Special Emphasis Panel; Vascular Alcoholism, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). and Hematology AREA Application Review. National Institute on Alcohol Abuse Date: July 31, 2018. Contact Person: Anna Ghambaryan, M.D., and Alcoholism; Notice of Closed Time: 1:00 p.m. to 4:00 p.m. Ph.D., Scientific Review Officer, Office of Meetings Extramural Activities, National Institute on Agenda: To review and evaluate grant Alcohol Abuse and Alcoholism, National applications. Pursuant to section 10(d) of the Institutes of Health, 5635 Fishers Lane, Place: National Institutes of Health, 6701 Federal Advisory Committee Act, as Rockville, MD 20852, anna.ghambaryan@ Rockledge Drive, Bethesda, MD 20892 amended, notice is hereby given of the nih.gov. (Telephone Conference Call). following meetings. (Catalogue of Federal Domestic Assistance Contact Person: Katherine M. Malinda, The meetings will be closed to the Program Nos. 93.271, Alcohol Research Ph.D., Scientific Review Officer, Center for public in accordance with the Career Development Awards for Scientists Scientific Review, National Institutes of provisions set forth in sections and Clinicians; 93.272, Alcohol National Health, 6701 Rockledge Drive, Room 4140, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Research Service Awards for Research MSC 7814, Bethesda, MD 20892, 301–435– as amended. The grant applications and Training; 93.273, Alcohol Research Programs; 0912, Katherine_Malinda@csr.nih.gov. the discussions could disclose 93.891, Alcohol Research Center Grants; Name of Committee: Center for Scientific confidential trade secrets or commercial 93.701, ARRA Related Biomedical Research Review Special Emphasis Panel; AREA: and Research Support Awards, National property such as patentable material, Institutes of Health, HHS) Immunology. and personal information concerning Date: August 2, 2018. individuals associated with the grant Dated: June 26, 2018. Time: 1:00 p.m. to 5:00 p.m. applications, the disclosure of which Melanie J. Pantoja, Agenda: To review and evaluate grant would constitute a clearly unwarranted Program Analyst, Office of Federal Advisory applications. invasion of personal privacy. Committee Policy. Place: National Institutes of Health, 6701 [FR Doc. 2018–14217 Filed 7–2–18; 8:45 am] Rockledge Drive, Bethesda, MD 20892 Name of Committee: National Institute on (Virtual Meeting). Alcohol Abuse and Alcoholism Special BILLING CODE 4140–01–P Contact Person: Liying Guo, Ph.D., Emphasis Panel; Medication Development for Scientific Review Officer, Center for Alcohol Use Disorders (PAR 18–578 & RFA Scientific Review, National Institutes of AA 18–009). DEPARTMENT OF HEALTH AND Health, 6701 Rockledge Drive, Room 4016F, Date: July 10, 2018. HUMAN SERVICES sradovich on DSK3GMQ082PROD with NOTICES Bethesda, MD 20892, 301–435–0908, lguo@ Time: 1:00 p.m. to 4:00 p.m. mail.nih.gov. Agenda: To review and evaluate grant National Institutes of Health applications. (Catalogue of Federal Domestic Assistance Place: National Institutes of Health, Center for Scientific Review; Notice of Program Nos. 93.306, Comparative Medicine; National Institute on Alcohol Abuse and Closed Meetings 93.333, Clinical Research, 93.306, 93.333, Alcoholism, 6700 B Rockledge Drive, 93.337, 93.393–93.396, 93.837–93.844, Bethesda, MD 20892 (Telephone Conference Pursuant to section 10(d) of the 93.846–93.878, 93.892, 93.893, National Call). Federal Advisory Committee Act, as Institutes of Health, HHS) VerDate Sep<11>2014 17:07 Jul 02, 2018 Jkt 244001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\03JYN1.SGM 03JYN1

Federal Register / Vol. 83, No. 128 / Tuesday, July 3, 2018 / Notices 31159 Dated: June 28, 2018. Dated: June 28, 2018. DEPARTMENT OF HEALTH AND Melanie J. Pantoja, David D. Clary, HUMAN SERVICES Program Analyst, Office of Federal Advisory Program Analyst, Office of Federal Advisory Committee Policy. Committee Policy. National Institutes of Health [FR Doc. 2018–14310 Filed 7–2–18; 8:45 am] [FR Doc. 2018–14309 Filed 7–2–18; 8:45 am] National Institute of Neurological BILLING CODE 4140–01–P BILLING CODE 4140–01–P Disorders and Stroke; Notice of Meeting DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND Pursuant to section 10(d) of the HUMAN SERVICES HUMAN SERVICES Federal Advisory Committee Act, as amended, notice is hereby given of the National Institutes of Health National Advisory Neurological National Institutes of Health Center for Scientific Review; Notice of Disorders and Stroke Council. Closed Meetings National Human Genome Research The meeting will be open to the Institute; Notice of Closed Meeting public as indicated below, with Pursuant to section 10(d) of the attendance limited to space available. Federal Advisory Committee Act, as Pursuant to section 10(d) of the Individuals who plan to attend and amended, notice is hereby given of the Federal Advisory Committee Act, as need special assistance, such as sign following meetings. amended, notice is hereby given of the language interpretation or other The meetings will be closed to the following meeting of the Center for reasonable accommodations, should public in accordance with the Inherited Disease Research Access notify the Contact Person listed below provisions set forth in sections Committee. in advance of the meeting. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., The meeting will be closed to the The meeting will be closed to the as amended. The grant applications and public in accordance with the public in accordance with the the discussions could disclose provisions set forth in sections provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., confidential trade secrets or commercial 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and property such as patentable material, as amended. The grant applications and the discussions could disclose and personal information concerning individuals associated with the grant the discussions could disclose confidential trade secrets or commercial applications, the disclosure of which confidential trade secrets or commercial property such as patentable materials, would constitute a clearly unwarranted property such as patentable material, and personal information concerning invasion of personal privacy. and personal information concerning individuals associated with the grant individuals associated with the grant applications, the disclosure of which Name of Committee: Center for Scientific Review Special Emphasis Panel; Vascular applications, the disclosure of which would constitute a clearly unwarranted and Hematology: Molecular and Cellular would constitute a clearly unwarranted invasion of personal privacy. Hematology. invasion of personal privacy. Name of Committee: National Advisory Date: July 23, 2018. Name of Committee: Center for Inherited Neurological Disorders and Stroke Council. Time: 2:00 p.m. to 3:00 p.m. Date: September 12–13, 2018. Disease Research Access Committee. Agenda: To review and evaluate grant Closed: September 12, 2018, 1:00 p.m. to Date: July 20, 2018. applications. 5:30 p.m. Place: National Institutes of Health, 6701 Time: 11:30 a.m. to 12:30 p.m. Agenda: To review and evaluate grant Rockledge Drive, Bethesda, MD 20892 Agenda: To review and evaluate grant applications. (Telephone Conference Call). applications. Place: National Institutes of Health, Contact Person: Luis Espinoza, Ph.D., Place: National Institutes of Health, 5635 Building 31, 31/6C, Conference Room 6, 31 Scientific Review Officer, Center for Fishers Lane, Room 3049, Bethesda, MD Center Drive, Bethesda, MD 20892. Scientific Review, National Institutes of 20892 (Telephone Conference Call). Closed: September 13, 2018, 8:00 a.m. to Health, 6701 Rockledge Drive, Room 4140, Contact Person: Barbara J. Thomas, Ph.D., 10:00 a.m. MSC 7814, Bethesda, MD 20892, 301–435– Scientific Review Officer, Scientific Review Agenda: To review and evaluate grant 0952, espinozala@mail.nih.gov. Branch, National Human Genome Research applications. Name of Committee: Center for Scientific Institute, National Institutes of Health, 5635 Place: National Institutes of Health, Review Special Emphasis Panel; Fishers Lane, Ste. 4076, MSC 9306, Bethesda, Building 31, 31/6C, Conference Room 6, 31 Lymphangiogenesis SEP. MD 20892–9306, 301–402–0838, Center Drive, Bethesda, MD 20892. Date: July 31, 2018. Open: September 13, 2018, 10:00 a.m. to barbara.thomas@nih.gov. Time: 2:00 p.m. to 4:00 p.m. 3:30 p.m. Agenda: To review and evaluate grant (Catalogue of Federal Domestic Assistance Agenda: Report by the Director, NINDS; applications. Program Nos. 93.172, Human Genome Report by the Director, Division of Place: National Institutes of Health, 6701 Research, National Institutes of Health, HHS) Extramural Activities; and Administrative Rockledge Drive, Bethesda, MD 20892 and Program Developments. Dated: June 27, 2018. (Telephone Conference Call). Place: National Institutes of Health, Contact Person: Larry Pinkus, Ph.D., Sylvia L. Neal, Building 31, 31/6C, Conference Room 6, 31 Scientific Review Officer, Center for Program Analyst, Office of Federal Advisory Center Drive, Bethesda, MD 20892. Scientific Review, National Institutes of Committee Policy. Contact Person: Robert Finkelstein, Ph.D., Health, 6701 Rockledge Drive, Room 4132, Director, Division of Extramural Activities, sradovich on DSK3GMQ082PROD with NOTICES [FR Doc. 2018–14311 Filed 7–2–18; 8:45 am] MSC 7802, Bethesda, MD 20892, (301) 435– National Institute of Neurological Disorders 1214, pinkusl@csr.nih.gov. BILLING CODE 4140–01–P and Stroke, NIH, 6001 Executive Blvd., Suite (Catalogue of Federal Domestic Assistance 3309, MSC 9531, Bethesda, MD 20892, (301) Program Nos. 93.306, Comparative Medicine; 496–9248. 93.333, Clinical Research, 93.306, 93.333, Any interested person may file written 93.337, 93.393–93.396, 93.837–93.844, comments with the committee by forwarding 93.846–93.878, 93.892, 93.893, National the statement to the Contact Person listed on Institutes of Health, HHS) this notice. The statement should include the VerDate Sep<11>2014 17:07 Jul 02, 2018 Jkt 244001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\03JYN1.SGM 03JYN1


Document Created: 2018-07-02 23:55:31
Document Modified: 2018-07-02 23:55:31
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJuly 17, 2018.
FR Citation83 FR 31158 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR